Search for: "In Interest of BM" Results 1 - 20 of 119
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
13 Feb 2013, 11:49 pm by Shamnad Basheer
This drug is of particular interest to India, given a roaring patent contest on this front between BMS and Ranbaxy before the Delhi High Court. [read post]
30 Apr 2021, 10:23 am by jeffreynewmanadmin
Of that amount, BMS will pay approximately $41 million, plus interest, to the United States, and the remainder to states participating in the settlement. [read post]
18 Aug 2021, 12:07 pm by jeffreynewmanadmin
 “We will continue to step in when corporations make decisions that compromise the interests, health, and wellbeing of our state’s residents. [read post]
20 Jul 2023, 3:44 am by Rose Hughes
 If readers are interested in hearing more about plausibility, tickets are still available for CIPA Congress on 3 October. [read post]
17 Mar 2013, 1:30 am by Shamnad Basheer
BDR sent a note to the patent office stating that it was clear that BMS was not interested in granting the license and that the information called for by BMS was irrelevant and nothing more than a delay tactic. [read post]
5 Jul 2012, 11:53 am by Tiffany Schmidt
Manipulations of the bargaining unit by employees signing up for shifts could pose an interesting dilemma for the City. [read post]
12 Sep 2012, 8:51 am by Tiffany Schmidt
In an interesting turn of events, the part-time firefighters have now called off the election to organize a union. [read post]
11 Aug 2014, 1:24 pm by Stephen Bilkis
If you are interested to discuss the issues in the case above, please do not hesitate to call our toll free number or visit our office near you. [read post]
4 Oct 2007, 7:55 am
The first thing the government alleged was that from 2000 through 2003 BMS knowingly and willfully paid illegal renumeration to physicians and other healthcare providers to induce them to purchase BMS drugs. [read post]
5 Aug 2013, 9:59 pm by Patent Docs
The UK High Court recently gave its judgment in the case of Merck, Sharp & Dohme Corp. and Bristol-Myers Squibb Pharmaceuticals Ltd (collectively referred to in the judgement as BMS) v Teva Pharma B.V. and Teva UK Ltd (Teva) (decision). [read post]
13 Aug 2014, 12:01 pm by Stephen Bilkis
BM offered no evidence to the contrary or otherwise challenged the presentence investigation report. [read post]
13 Aug 2014, 12:01 pm by Stephen Bilkis
BM offered no evidence to the contrary or otherwise challenged the presentence investigation report. [read post]
11 May 2023, 2:21 am by Aida Tohala (Bristows)
As such, it is of great relevance to practitioners interested in the evolution of this legal concept. [read post]
3 Sep 2015, 7:34 am by Law Offices of Jeffrey S. Glassman
It is interesting to see that none of the drug companies are able to claim their respective drug wont kill you, nor are they saying they have identified the risk factors, so people at higher risk could avoid taking the drugs. [read post]
7 Apr 2011, 1:51 am by Adam Wagner
On the basis of the matters for which there are reasonable grounds for suspicion, [BM] represents a considerable danger to public safety. [read post]
31 Jan 2013, 2:39 pm by Prashant Reddy
 So what insurance did BMS take out before striking the deal with Emcure? [read post]
18 Oct 2011, 8:31 am by Lawrence B. Ebert
Apotex contends that under both Federal law and the FTC’s prior judgments, BMS had a duty to inform the FTC of its oral promise not to launch an authorized generic. [read post]
4 Jan 2019, 9:16 pm
The launch of a public consultation for the Orphan Drugs Regulation, revealing the interest of the Commission in the application of the Regulation,     suggests that a revision of the Regulation might in fact be underway. [read post]
19 Jan 2010, 1:26 am by Old Fox
(SPG)Place a limit order to buy the Simon Property Group February 65 call (SPG BM) at a maximum entry price of $11.50. [read post]
15 Jan 2009, 3:35 am
By Vandana Mamidanna Following on from this week's IP Think Tank podcast which analysed the BMS v Hetero case. [read post]